It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
In the last several years, global market of Classical Swine Fever Vaccines developed steadily, with an average growth rate of 5%. In 2017, global sales revenue of Classical Swine Fever Vaccines is nearly 140 M USD; the actual sale is about 4.21 billion doses.
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2017 is about 60.7%. And the proportion of Cell Line Origin in 2016 is about 39.3%.
Classical Swine Fever Vaccines is application in Government Tender and Market Sales. The most of Classical Swine Fever Vaccines Are Market Sales, and the market share in 2017 is about 95.1%.

According to this study, over the next five years the Classical Swine Fever Vaccines market will register a 3.8% CAGR in terms of revenue, the global market size will reach US$ 180 million by 2024, from US$ 150 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Classical Swine Fever Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Classical Swine Fever Vaccines market by product type, application, key manufacturers and key regions and countries.

This study considers the Classical Swine Fever Vaccines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tissue Culture Origin
Cell Line Origin
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Government Tender
Market Sales

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Classical Swine Fever Vaccines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Classical Swine Fever Vaccines market by identifying its various subsegments.
Focuses on the key global Classical Swine Fever Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Classical Swine Fever Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Classical Swine Fever Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.